RESUMEN
Lysyl oxidase (LOX) oxidizes the side chain of peptidyl lysine converting specific lysine residues to residues of alpha-aminoadipic-delta-semialdehyde. This posttranslational chemical change permits the covalent crosslinking of the component chains of collagen and those of elastin, thus stabilizing the fibrous deposits of these proteins in the extracellular matrix. Four LOX-like (LOXL) proteins with varying degrees of similarity to LOX have been described, constituting a family of related proteins. LOX is synthesized as a preproprotein which emerges from the cell as proLOX and then is processed to the active enzyme by proteolysis. In addition to elastin and collagen, LOX can oxidize lysine within a variety of cationic proteins, suggesting that its functions extend beyond its role in the stabilization of the extracellular matrix. Indeed, recent findings reveal that LOX and LOXL proteins markedly influence cell behavior including chemotactic responses, proliferation, and shifts between the normal and malignant phenotypes.
Asunto(s)
Lisina/metabolismo , Proteína-Lisina 6-Oxidasa/química , Proteína-Lisina 6-Oxidasa/fisiología , Animales , Catálisis , Proliferación Celular , Transformación Celular Neoplásica , Quimiotaxis/fisiología , Coenzimas/fisiología , Lisina/química , Modelos Moleculares , Oxidación-Reducción , Procesamiento Proteico-Postraduccional , Proteína-Lisina 6-Oxidasa/análisis , Especificidad por SustratoRESUMEN
Lysyl oxidase is an extracellular enzyme that catalyzes cross-linkages of extracellular matrix proteins. We hypothesized that this enzyme is secreted by cells attracted to central nervous system injury sites and is involved in extracellular matrix modulation and in scar formation. Specific antibodies for immunohistochemistry and enzyme activity measurements were used to detect the presence of lysyl oxidase after longitudinal knife cuts in adult rat forebrain. Immunoreactivity was observed within the core of injury sites from 1 and up to 30 days postoperative, with less staining at 2 and 5 days, and was not associated with glial fibrillary acidic protein-positive astrocytes. Enzyme activity increased transiently in injury site regions with a peak (200% of control) at 10 days postoperative. These results are the first to provide evidence for a time-dependent appearance of active extracellular lysyl oxidase in brain injury sites. They imply that enzyme molecules are synthesized and secreted by cells attracted to brain injury sites and participate in extracellular matrix modulation.
Asunto(s)
Lesiones Encefálicas/enzimología , Proteínas de la Matriz Extracelular/biosíntesis , Matriz Extracelular/enzimología , Proteína-Lisina 6-Oxidasa/metabolismo , Animales , Lesiones Encefálicas/patología , Plexo Coroideo/anatomía & histología , Plexo Coroideo/patología , Plexo Coroideo/fisiología , Proteína Ácida Fibrilar de la Glía/metabolismo , Arteria Hepática/patología , Arteria Hepática/fisiología , Inmunohistoquímica , Masculino , Regeneración Nerviosa/fisiología , Ratas , Heridas Punzantes/enzimologíaRESUMEN
Histatin 5 is a low molecular weight salivary protein which is known to exhibit inhibitory activity against several proteinases, including the cysteine proteinases gingipains. The purpose of this study was to characterize the effect of salivary histatin on the proteolytic activity of the cysteine proteinase clostripain derived from the pathogen Clostridium histolyticum. Using a synthetic nitroanilide substrate, we studied in detail the inhibition of clostripain by histatin 5 and compared the effect of this peptide to that of leupeptin, a known competitive inhibitor of clostripain. It was found that the concentration of histatin 5 required to inhibit 50% of clostripain activity was 23.6+/-1.6 nM. Kinetic analysis revealed that histatin 5 is a competitive inhibitor of clostripain with an inhibition constant (K(i)) of 10 nM. The K(i) for the inhibition of clostripain activity against nitroanilide substrate by leupeptin was found to be 60 nM, significantly higher than that of histatin 5. Thus, histatin 5 inhibits clostripain more effectively than leupeptin and other cysteine protease inhibitors studied here. No significant proteolysis of histatin 5 was observed when histatin 5 was incubated at physiologic concentrations with clostripain. The potent inhibition of clostripain by histatin 5 points towards the possibility that this protein may prevent establishment of clostridial infections and therefore may have significant potential for the treatment of diseases associated with this enzyme.
Asunto(s)
Cisteína Endopeptidasas/metabolismo , Inhibidores de Cisteína Proteinasa/farmacología , Proteínas y Péptidos Salivales/farmacología , Secuencia de Aminoácidos , Unión Competitiva , Cisteína Endopeptidasas/efectos de los fármacos , Histatinas , Humanos , Cinética , Leupeptinas/farmacología , Datos de Secuencia Molecular , Glándulas Salivales/químicaRESUMEN
The several steps in the pathway for the biosynthesis of fibrillar collagen are reviewed to illustrate potential sites for the chemotherapeutic control of fibrosis. Particular emphasis is placed upon the properties and inhibition of lysyl oxidase, the enzyme which initiates the covalent crosslinking of extracellular collagen molecules converting these to insoluble fibers, and upon the properties and inhibition of prolyl hydroxylase, the intracellular enzyme which hyroxylates proline residues within collagen.
Asunto(s)
Colágeno/biosíntesis , Inhibidores Enzimáticos/farmacología , Procolágeno-Prolina Dioxigenasa/antagonistas & inhibidores , Proteína-Lisina 6-Oxidasa/antagonistas & inhibidores , Aminopropionitrilo/farmacología , Animales , Bencilaminas/farmacología , Células Cultivadas , Colágeno/genética , Ésteres/farmacología , Etilaminas/farmacología , Fibrosis/prevención & control , Humanos , Lactonas/farmacología , Procolágeno-Prolina Dioxigenasa/metabolismo , Proteína-Lisina 6-Oxidasa/metabolismoRESUMEN
Lysyl oxidase (LO), a secreted protein, was recently identified within the nuclei of vascular smooth-muscle cells (SMC) and 3T3 fibroblasts. A possible pathway by which LO can enter cell nuclei was explored in the present study. SMC were incubated with purified 32-kDa bovine aorta LO that had been fluorescently labeled with rhodamine (TRITC-LO). TRITC-LO entered the cytosol and then rapidly concentrated within the nuclei of preconfluent cultures of these cells, whereas carbonic anhydrase, a protein of similar molecular weight and similarly labeled, did not enter the cells under these conditions. LO that had been reductively methylated at lysine residues with [(14)C]HCHO was also taken up into the cytosolic and nuclear compartments. Intracellular uptake and intracellular distribution were not altered by inhibiting LO activity with beta-aminopropionitrile. An excess of native LO but not of carbonic anhydrase competitively inhibited the uptake of the isotopically labeled enzyme. Thus, once secreted and proteolytically processed, mature LO can enter the cells and concentrate within nuclei in a manner that appears to be specific and independent of its catalytic activity.
Asunto(s)
Músculo Liso Vascular/enzimología , Proteína-Lisina 6-Oxidasa/metabolismo , Células 3T3 , Animales , Aorta/citología , Aorta/metabolismo , Transporte Biológico Activo , Bovinos , Núcleo Celular/enzimología , Células Cultivadas , Espacio Extracelular/enzimología , Colorantes Fluorescentes , Ratones , Músculo Liso Vascular/citología , Procesamiento Proteico-Postraduccional , Proteína-Lisina 6-Oxidasa/química , Ratas , RodaminasRESUMEN
Lysyl oxidase (LO), an enzyme secreted by vascular smooth muscle cells (VSMC), initiates the covalent crosslinking of polypeptide chains within collagen and elastin. The present study reveals that purified LO strongly induces directional migration of VSMC in an in vitro assay system. LO-dependent chemotaxis, but not chemokinesis, was abolished by beta-aminopropionitrile, an active site inhibitor of LO, or by catalase, as well as by prior heat denaturation. This indicates that the H(2)O(2) product of amine oxidation by LO is critical to the expression of its chemotactic activity. The results indicate that the chemotactic response requires direct access between LO and a substrate molecule (or molecules) tightly associated with the VSMC. The addition of LO to VSMC elevated the levels of intracellular H(2)O(2), enhanced stress fiber formation, and focal adhesion assembly, is consistent with the induction of the chemotactic response.
Asunto(s)
Quimiotaxis/efectos de los fármacos , Peróxido de Hidrógeno/metabolismo , Músculo Liso Vascular/enzimología , Músculo Liso Vascular/metabolismo , Proteína-Lisina 6-Oxidasa/metabolismo , Citoesqueleto de Actina/enzimología , Aminopropionitrilo/farmacología , Animales , Aorta/enzimología , Aorta/metabolismo , Catalasa/farmacología , Bovinos , Adhesión Celular/efectos de los fármacos , Células Cultivadas , Relación Dosis-Respuesta a Droga , Microscopía Fluorescente , Proteína-Lisina 6-Oxidasa/farmacología , RatasRESUMEN
Lysyl oxidase (LO) is a key participant in the accumulation of insoluble fibers of elastin and collagen by virtue of its role in the initiation of the covalent cross-linkages between and within individual molecules comprising these fibers. In view of the essential role played by LO in the accumulation of the fibrotic components of occlusive arterial lesions in atherosclerosis, identification of the signaling molecules which can affect the expression of the LO gene in vascular smooth muscle is of considerable interest. In the present report, we describe evidence for the role of the second messenger, cAMP, in the modulation of the levels of LO in vascular smooth muscle cells. Elevated intracellular cAMP induces the transcription of the LO gene, as revealed by Northern blot analysis and nuclear run on assays. Transient transfection experiments performed with the wild-type LO promoter and with this promoter mutated at a consensus CREB site, located within the region -100 to -93 base pairs relative to the start of transcription, indicate that cAMP-induced transcriptional activation is partially due to the presence of this CREB site within the promoter. Activation of stimulatory adenosine receptors in vascular smooth muscle cells with 5'-N-ethylcarboxamido adenosine (NECA) increases cAMP, LO mRNA, and enzyme activity. These findings point to the importance of cAMP signaling, potentially initiated by a variety of physiological agents, in the upregulation of LO expression in vascular smooth muscle cells.
Asunto(s)
AMP Cíclico/farmacología , Músculo Liso Vascular/efectos de los fármacos , Proteína-Lisina 6-Oxidasa/genética , Receptores Purinérgicos P1/metabolismo , Adenosina-5'-(N-etilcarboxamida)/farmacología , Animales , Aorta , Recuento de Células/efectos de los fármacos , Células Cultivadas , Colforsina/farmacología , AMP Cíclico/metabolismo , ADN/biosíntesis , Activación Enzimática , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Músculo Liso Vascular/enzimología , Regiones Promotoras Genéticas , Proteína-Lisina 6-Oxidasa/metabolismo , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Regulación hacia ArribaRESUMEN
The mixture of proteins secreted by neonatal rat aorta smooth muscle cells cultured in the presence of beta-aminopropionitrile was readily oxidized and polymerized upon incubation with purified or crude preparations of lysyl oxidase. Western blot analysis indicated that these substrates included 30-60kDa protein bands reactive with anti-elastin, presumed to be fragments derived from tropoelastin. Thus, truncated, elastin-like as well as other proteins accumulate in the media of these cultures which, in toto, can serve as a conveniently prepared, highly efficient substrate for the routine assay of lysyl oxidase activity.
Asunto(s)
Elastina/metabolismo , Proteínas Musculares/metabolismo , Músculo Liso Vascular/metabolismo , Proteína-Lisina 6-Oxidasa/metabolismo , Animales , Animales Recién Nacidos , Aorta , Western Blotting , Células Cultivadas , Peso Molecular , Músculo Liso Vascular/citología , Oxidación-Reducción , RatasRESUMEN
The reaction of lysyl oxidase was assessed with members of a series of aminoalkylaziridines in which the primary amino group and the aziridinyl nitrogen were separated by 3-7 methylene carbons. Among these, N-(5-aminopentyl)aziridine proved to be the poorest substrate by far and to inhibit the enzyme activity. Aminoalkylaziridines with chain lengths shorter or longer than five carbons did not inhibit the enzyme. The resulting inhibition was competitive with productive substrates and became irreversible with time, following pseudo first order kinetics with a KI of 0.22 mM. N-(5-aminopentyl)aziridine appears to act as a bifunctional affinity label covalently interacting with the active site of this enzyme.
Asunto(s)
Aminas/metabolismo , Aminas/farmacología , Aziridinas/metabolismo , Aziridinas/farmacología , Proteína-Lisina 6-Oxidasa/antagonistas & inhibidores , Alquilación , Aminas/química , Aziridinas/química , Unión Competitiva , Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/metabolismo , Inhibidores Enzimáticos/farmacología , Proteína-Lisina 6-Oxidasa/aislamiento & purificación , Proteína-Lisina 6-Oxidasa/metabolismo , Proteína-Lisina 6-Oxidasa/fisiología , Especificidad por SustratoRESUMEN
Lysyl oxidase (LO) is a copper-dependent amine oxidase that plays a critical role in the biogenesis of connective tissue matrices by crosslinking the extracellular matrix proteins, collagen and elastin. Levels of LO increase in many fibrotic diseases, while expression of the enzyme is decreased in certain diseases involving impaired copper metabolism. While the three-dimensional structure of the enzyme is not yet available, many of its physical-chemical properties, its novel carbonyl cofactor, and its catalytic mechanism have been described. Lysyl oxidase is synthesized as a preproprotein, secreted as a 50 kDa, N-glycosylated proenzyme and then proteolytically cleaved to the 32 kDa, catalytically active, mature enzyme. Within the past decade, the gene encoding LO has been cloned, facilitating investigations of the regulation of expression of the enzyme in response to diverse stimuli and in numerous disease states. Transforming growth factor-beta, platelet-derived growth factor, angiotensin II, retinoic acid, fibroblast growth factor, altered serum conditions, and shear stress are among the effectors or conditions that regulate LO expression. New, LO-like genes have also been identified and cloned, suggesting the existence of a multigene family. It has also become increasingly evident that LO may have other important biological functions in addition to its role in the crosslinking of elastin and collagen in the extracellular matrix.
Asunto(s)
Proteína-Lisina 6-Oxidasa/fisiología , Animales , Humanos , Modelos Químicos , Proteína-Lisina 6-Oxidasa/genéticaRESUMEN
Lysyl oxidase (EC 1.4.3.13) oxidizes peptidyl lysine to peptidyl aldehyde residues within collagen and elastin, thus initiating formation of the covalent cross-linkages that insolubilize these extracellular proteins. Recent findings raise the possibility that this enzyme may also function intracellularly. The present study provides evidence by immunocytochemical confocal microscopy, Western blot analysis, enzyme assays, and chemical analyses for lysyl oxidase reaction products that this enzyme is present and active within rat vascular smooth muscle cell nuclei. Confocal microscopy indicates its presence within nuclei of 3T3 fibroblasts, as well.
Asunto(s)
Núcleo Celular/enzimología , Músculo Liso Vascular/enzimología , Proteína-Lisina 6-Oxidasa/metabolismo , Secuencia de Aminoácidos , Animales , Western Blotting , Catálisis , Células Cultivadas , Inmunohistoquímica , Microscopía Confocal , Datos de Secuencia Molecular , Proteínas Nucleares/metabolismo , RatasRESUMEN
Transforming growth factor-beta 1 (TGF-beta 1) markedly reduced cell proliferation and elevated steady state lysyl oxidase (LO) mRNA 3-fold in neonatal rat aorta smooth muscle cells cultured in medium containing 10% fetal bovine serum. The increase in LO mRNA was prevented by the presence of cycloheximide, indicative of controlling events at the level of protein synthesis. The basal level of mRNA in cells proliferating in 10% fetal bovine serum in the absence of TGF-beta 1 was enhanced 7-fold upon decreasing growth by shifting to medium containing 0.5% serum. Changes in LO activity paralleled those in LO mRNA. Nuclear run-on assays revealed that the stimulation of expression in 0.5% serum involved increased gene transcription whereas that caused by TGF-beta 1 was mostly post-transcriptional in origin. LO mRNA was quite labile (t1/2 approximately 3 h) in 10% serum but was markedly stabilized (t1/2 > 12 h) by the presence of TGF-beta 1 in the 10% serum medium. LO mRNA was also considerably more stable under retarded growth conditions (0.5% serum) in the absence of TGF-beta 1. LO promoter activity in luciferase reporter constructs transfected into these cells was low and not significantly affected by the addition of TGF-beta 1 to the 10% serum medium but was markedly elevated by shifting from 10 to 0.5% serum in the absence of TGF-beta 1. Thus, LO expression is inversely correlated with cell proliferation, and is subject to control at transcriptional and post-transcriptional levels. TGF-beta 1 enhances LO expression in these cells by dramatically stabilizing LO mRNA.
Asunto(s)
Medio de Cultivo Libre de Suero , Regulación Enzimológica de la Expresión Génica , Músculo Liso Vascular/enzimología , Proteína-Lisina 6-Oxidasa/genética , Transcripción Genética , Factor de Crecimiento Transformador beta/farmacología , Animales , Animales Recién Nacidos , Aorta , Células Cultivadas , Estabilidad de Medicamentos , Humanos , Cinética , Luciferasas/genética , Regiones Promotoras Genéticas , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Proteínas Recombinantes de Fusión , Factor de Crecimiento Transformador beta/administración & dosificaciónRESUMEN
The human fetal membranes provide a sterile biomechanical container which adjust by growth to mid-pregnancy to the increase in fetal size, and by elasticity to the forceful movements of the fetus. The molecular basis for this elasticity is not known, yet reduced elasticity may lead to their premature rupture and preterm birth, a major problem in perinatal medicine. Classically, elastin confers the property of elastic recoil to elastic fibres which are assembled from a family of tropoelastin precursors. These are covalently cross-linked to form insoluble elastin by formation of desmosine and isodesmosine, catalysed by the enzyme lysyl oxidase. The amnion, chorion and decidua were shown by Northern analysis and RT-PCR to contain detectable levels of tropoelastin mRNA and the mRNA encoding lysyl oxidase. The proteins encoded by these mRNAs were also identified by Western blotting and immunolocalization. Further, insoluble elastin was extracted from the human fetal membranes and shown by comparison to elastin preparations from other elastic tissues to have a reasonable desmosine content. Finally, scanning electron microscopy confirmed the presence of multiple layers of an apparently very thin elastic system in this tissue. This biochemical and histopathologic study has demonstrated therefore that the human fetal membranes synthesize and deposit a novel elastic fibre. The presence of such an elastic system in these tissues provides, for the first time, a probable molecular basis for the elastic properties of this tissue.
Asunto(s)
Elastina/análisis , Membranas Extraembrionarias/química , Membranas Extraembrionarias/fisiología , Aminoácidos/análisis , Amnios/química , Northern Blotting , Corion/química , Decidua/química , Desmosina/análisis , Elasticidad , Femenino , Humanos , Inmunohistoquímica , Microscopía Electrónica de Rastreo , Reacción en Cadena de la Polimerasa , Embarazo , Proteína-Lisina 6-Oxidasa/genética , ARN Mensajero/análisis , Tropoelastina/genéticaRESUMEN
Homocysteine thiolactone, selenohomocysteine lactone, and homoserine lactone were found to be competitive, irreversible inhibitors of lysyl oxidase, with KI values of 21 +/- 3 microM, 8.3 +/- 2.2 microM, and 420 +/- 56 microM, respectively. The first order rate constants for inactivation (k2) of the enzyme varied over a much smaller range, ranging from 0.12 to 0.18 to 0.28 min-1 for the Se-, thio-, and O-lactones, respectively. Mutually exclusive labeling of the enzyme by [1-14C]beta-aminopropionitrile, [U-14C]phenylhydrazine, or [35S]homocysteine thiolactone was observed. These labeling results, together with the closely similar perturbations of the near UV-visible spectra of lysyl oxidase and of a model of its lysine tyrosylquinone cofactor by the thiolactone, indicate that the lactones likely derivatize and reduce the active site carbonyl cofactor. Substitution with deuterium at the alpha-carbon of the thiolactone caused a deuterium kinetic isotope effect on k2 of 3.2 +/- 0.2, consistent with the involvement of rate-limiting alpha-proton abstraction during lactone-induced inactivation of the enzyme. The activities of plasma amine oxidase and diamine oxidase were only minimally reduced at concentrations of the sulfur or selenium lactones that fully inhibited lysyl oxidase. Thus, these lactones constitute a new category of mechanism-based inactivators selective for lysyl oxidase. Further, these results may relate to the development of connective tissue defects seen in homocystinuria.
Asunto(s)
Inhibidores Enzimáticos/farmacología , Homocisteína/análogos & derivados , Homocistinuria/enzimología , Oxígeno/química , Proteína-Lisina 6-Oxidasa/antagonistas & inhibidores , Selenio/química , Animales , Bovinos , Inhibidores Enzimáticos/química , Homocisteína/química , Homocisteína/farmacología , Marcaje Isotópico , Cinética , Análisis Espectral , Compuestos de Sulfhidrilo/análisis , Radioisótopos de Azufre , PorcinosRESUMEN
Prostaglandin E2, transforming growth factor-beta, and interleukin-1 beta variably regulate the expression of cyclooxygenase 1, cyclooxygenase 2, and lysyl oxidase in IMR90, human embryo lung fibroblasts. Prostaglandin E2 at 100 nM upregulates cyclooxygenase 1 mRNA by approximately three-fold while it downregulates lysyl oxidase mRNA levels. Notably, prostaglandin E2 suppresses the enhancing effect of TGF-beta on basal levels of lysyl oxidase mRNA. These changes in steady state mRNA levels reflect transcriptional level control, at least in part. Corresponding changes are seen in the protein levels of lysyl oxidase, cyclooxygenase 1 and cyclooxygenase 2 and catalytic activities of these enzymes, including net prostaglandin E2 synthesis. Cyclooxygenase 2 mRNA(t1/2, 30 min) is considerably less stable than that of cyclooxygenase 1 (t1/2, 4 h) while lysyl oxidase mRNA is unusually stable (t1/2 > 14 h). Taken together with the differing kinetics with which these genes respond to perturbation by these cytokines, the present results suggest a coordinated, autocrine-like mechanism of regulation of cyclooxygenase 1 and cyclooxygenase 2 and further point to the potential of their metabolic product, prostaglandin E2, to suppress the expression of lysyl oxidase in the inflammatory response to injury.
Asunto(s)
Interleucina-1/metabolismo , Pulmón/metabolismo , Prostaglandina-Endoperóxido Sintasas/metabolismo , Proteína-Lisina 6-Oxidasa/metabolismo , Factor de Crecimiento Transformador beta/metabolismo , Ciclooxigenasa 1 , Ciclooxigenasa 2 , Dactinomicina/farmacología , Dinoprostona/metabolismo , Regulación hacia Abajo , Fibroblastos/efectos de los fármacos , Fibroblastos/metabolismo , Humanos , Interleucina-1/farmacología , Isoenzimas/efectos de los fármacos , Isoenzimas/genética , Isoenzimas/metabolismo , Pulmón/citología , Pulmón/efectos de los fármacos , Proteínas de la Membrana , Pruebas de Precipitina , Prostaglandina-Endoperóxido Sintasas/efectos de los fármacos , Prostaglandina-Endoperóxido Sintasas/genética , Proteína-Lisina 6-Oxidasa/efectos de los fármacos , Proteína-Lisina 6-Oxidasa/genética , Transcripción Genética , Factor de Crecimiento Transformador beta/farmacología , Regulación hacia ArribaRESUMEN
A previously unknown redox cofactor has been identified in the active site of lysyl oxidase from the bovine aorta. Edman sequencing, mass spectrometry, ultraviolet-visible spectra, and resonance Raman studies showed that this cofactor is a quinone. Its structure is derived from the crosslinking of the epsilon-amino group of a peptidyl lysine with the modified side chain of a tyrosyl residue, and it has been designated lysine tyrosylquinone. This quinone appears to be the only example of a mammalian cofactor formed from the crosslinking of two amino acid side chains. This discovery expands the range of known quino-cofactor structures and has implications for the mechanism of their biogenesis.
Asunto(s)
Lisina/análogos & derivados , Proteína-Lisina 6-Oxidasa/química , Quinonas/química , Secuencia de Aminoácidos , Animales , Aorta/enzimología , Sitios de Unión , Bovinos , Cromatografía Líquida de Alta Presión , Lisina/química , Lisina/metabolismo , Espectrometría de Masas , Datos de Secuencia Molecular , Peso Molecular , Mutagénesis Sitio-Dirigida , Oxidación-Reducción , Proteína-Lisina 6-Oxidasa/genética , Proteína-Lisina 6-Oxidasa/aislamiento & purificación , Proteína-Lisina 6-Oxidasa/metabolismo , Quinonas/metabolismo , Espectrofotometría Ultravioleta , Espectrometría RamanRESUMEN
Lysyl oxidase is secreted from fibrogenic cells as a 50-kDa proenzyme that is proteolytically processed to the mature enzyme in the extracellular space. To characterize the secreted proteinase activity, a truncated, recombinant form of lysyl oxidase was prepared as a proteinase substrate containing the sequence of the propeptide cleavage region. The processing proteinase activity secreted by cultured fibrogenic cells resists inhibitors of serine or aspartyl proteinases as well as tissue inhibitor of matrix metalloproteinases-2 (MMP-2) but is completely inhibited by metal ion chelators. Known metalloproteinases were tested for their activity toward this substrate. Carboxyl-terminal procollagen proteinase (C-proteinase), MMP-2, and conditioned fibrogenic cell culture medium cleave the lysyl oxidase substrate to the size of the mature enzyme. The NH2-terminal sequence generated by arterial smooth muscle conditioned medium and the C-proteinase but not by MMP-2, i.e. Asp-Asp-Pro-Tyr, was identical to that previously identified in mature lysyl oxidase isolated from connective tissue. The C-proteinase activity against the model substrate was inhibited by a synthetic oligopeptide mimic of the cleavage sequence (Ac-Met-Val-Gly-Asp-Asp-Pro-Tyr-Asn-amide), whereas this peptide also inhibited the generation of lysyl oxidase activity in the medium of fetal rat lung fibroblasts in culture. In toto, these results identify a secreted metalloproteinase activity participating in the activation of prolysyl oxidase, identify inhibitors of the processing activity, and implicate procollagen C-proteinase in this role.
Asunto(s)
Proteínas Morfogenéticas Óseas , Metaloendopeptidasas/metabolismo , Precursores de Proteínas/metabolismo , Procesamiento Proteico-Postraduccional , Proteína-Lisina 6-Oxidasa/metabolismo , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Proteína Morfogenética Ósea 1 , Células Cultivadas , Tejido Conectivo/enzimología , Humanos , Hidrólisis , Datos de Secuencia Molecular , Músculo Liso Vascular/enzimología , Oligodesoxirribonucleótidos , Ratas , Homología de Secuencia de AminoácidoRESUMEN
Lysyl oxidase highly purified from calf aorta was found to be a potent chemotactic agent for unstimulated human peripheral blood mononuclear cells, determined in in vitro assays in Boyden chambers. A typical chemotactic bell-shaped curve was observed, with a maximal migratory response of 237% of control occurring at 10(-10) M lysyl oxidase. The chemotactic response was prevented by prior heat inactivation of the enzyme, by treatment of the enzyme with beta-aminopropionitrile or ethylenediamine, which are active site-directed inhibitors of lysyl oxidase, and by a competing, lysine-containing peptide substrate of lysyl oxidase. The chemoattractant response to lysyl oxidases was characterized by both chemokinetic and chemotactic components. These results raise the possibility that extracellular lysyl oxidase may have important roles to play in biology in addition to its established function in the crosslinking of elastin and collagen.
Asunto(s)
Factores Quimiotácticos/farmacología , Quimiotaxis de Leucocito/efectos de los fármacos , Leucocitos Mononucleares/efectos de los fármacos , Proteína-Lisina 6-Oxidasa/farmacología , Aminopropionitrilo/farmacología , Animales , Sitios de Unión/efectos de los fármacos , Bovinos , Células Cultivadas , Factores Quimiotácticos/antagonistas & inhibidores , Inhibidores Enzimáticos/farmacología , Etilenodiaminas/farmacología , Humanos , Proteína-Lisina 6-Oxidasa/antagonistas & inhibidoresRESUMEN
Rat aortic lysyl oxidase cDNA was expressed under a metallothionein promoter in Chinese hamster ovary cells using a dihydrofolate reductase selection marker. One methotrexate-resistant cell line, LOD-06, generated by transfecting with full-length cDNA, yielded lysyl oxidase proteins consistent with the 50 kDa proenzyme and a 29 kDa mature catalyst. A second cell line, LOD32-2, was generated by transfection with a truncated cDNA lacking sequences which code for the bulk of the propeptide region. Both cell lines secreted apparently identical, 29 kDa forms of mature lysyl oxidase each of which catalyzed the deamination of human recombinant tropoelastin and alkylamines, consistent with the known specificity of lysyl oxidase. The secreted enzyme forms were inhibited by chemical inhibitors of lysyl oxidase activity, including beta-aminopropionitrile, phenylhydrazine, ethylenediamine, alpha, alpha'-dipyridyl, and diethyldithiocarbamate. Sensitivity to these agents is consistent with the presence of copper and carbonyl cofactors in the expressed enzymes, characteristic of lysyl oxidase from connective tissues. These results indicate the lack of essentiality of the deleted proprotein sequence for the proper folding, generation of catalytic function, and secretion of lysyl oxidase.
Asunto(s)
Expresión Génica , Pliegue de Proteína , Precursores de Proteínas/química , Proteína-Lisina 6-Oxidasa/química , Proteína-Lisina 6-Oxidasa/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Western Blotting , Células CHO , Catálisis , Cricetinae , ADN Complementario/genética , Inhibidores Enzimáticos/farmacología , Humanos , Metalotioneína/genética , Ratones , Datos de Secuencia Molecular , Peso Molecular , Regiones Promotoras Genéticas , Precursores de Proteínas/metabolismo , Proteína-Lisina 6-Oxidasa/metabolismo , Ratas , Relación Estructura-Actividad , TransfecciónRESUMEN
Lysyl oxidase, a copper-dependent metalloenzyme, plays a central role in crosslinking of collagen and elastin in the extracellular matrix. Notably, lung lysyl oxidase activity is markedly stimulated in rats exposed to cadmium vapors. To further understand the mechanism of cadmium toxicity, the mRNA expression, synthesis, post-translational processing, and catalytic activity of lysyl oxidase were examined in cadmium-resistant (CdR) cells and the cadmium-sensitive Swiss mouse 3T3 cells from which they were derived. These CdR cells synthesized and accumulated markedly elevated levels of metallothionein, a known marker for cadmium resistance, whereas the expression of lysyl oxidase was reduced considerably. In comparison to the parental, cadmium-sensitive cells, the suppression of enzyme production in the CdR cells was seen at the mRNA level, at the levels of intracellular proprotein production and mature enzyme secreted into the medium, and in terms of total enzyme activity in the culture. The presence of cupric chloride in the culture medium during the incubation of the CdR cells for 16 h significantly enhanced lysyl oxidase activity accumulating in the medium, suggesting that lysyl oxidase deficiency in CdR cells may be related to abnormal copper metabolism.